Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:555-562
Published online before print December 29, 2005, doi: 10.1161/01.ATV.0000202028.62414.3c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/3/555    most recent
01.ATV.0000202028.62414.3cv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tilley, R. E.
Right arrow Articles by Mackman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tilley, R. E.
Right arrow Articles by Mackman, N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:555.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression

Rachel E. Tilley; Brian Pedersen; Rafal Pawlinski; Yuichiro Sato; Jonathan H. Erlich; Yuechun Shen; Sharlene Day; Ying Huang; Daniel T. Eitzman; William A. Boisvert; Linda K. Curtiss; William P. Fay; Nigel Mackman

From the Department of Immunology (R.E.T., B.P., R.P., Y.S., L.K.C., N.M.), The Scripps Research Institute, La Jolla, Calif; the Department of Cell Biology (N.M.), The Scripps Research Institute, La Jolla, Calif; University of New South Wales (J.H.E.), Sydney, Australia; the Department of Internal Medicine (Y.S., S.D., Y.H., D.T.E.), University of Michigan Medical School, Ann Arbor, Mich; the Department of Vascular Medicine Research (W.A.B.), Harvard Medical School, Cambridge, Mass; and the Department of Internal Medicine (W.P.F.), University of Missouri at Columbia, Mo.

Correspondence to Nigel Mackman, The Scripps Research Institute,10550 North Torrey Pines Road, CVN-18, La Jolla, CA 92037. E-mail nmackman{at}scripps.edu

Objective— To determine whether tissue factor (TF) contributes to the progression of atherosclerotic lesions in mice.

Methods and Results— We determined the effect of a 50% reduction of TF levels in all cells on atherosclerosis in apolipoprotein E-deficient (apoE–/–) mice. No differences were observed in the extent of atherosclerosis in apoE–/–/TF+/+ and apoE–/–/TF+/– mice fed regular chow for 34 weeks. Atherosclerosis could not be analyzed in apoE–/– mice expressing low levels of TF because of premature death of these mice. Macrophages are a major source of TF in atherosclerotic plaques. Therefore, in a second series of experiments, we investigated the effect on atherosclerosis of selectively reducing hematopoietic cell-derived TF by transplanting bone marrow from mice expressing low levels of TF into low-density lipoprotein receptor deficient (LDLR–/–) mice. Atherosclerosis within the arterial tree and aortic root were similar in LDLR–/– mice with low-TF bone marrow compared with control bone marrow (TF+/+ or TF+/–) after 4 and 16 weeks on an atherogenic diet. Furthermore, the cellular composition of the aortic root lesions was similar between the 2 groups.

Conclusions— Our data indicate that either a 50% reduction of TF in all cells or a selective reduction in hematopoietic cell-derived TF does not affect the development of atherosclerotic lesions in mice.

We sought to determine whether tissue factor (TF) contributes to the progression of atherosclerotic lesions in mice. A 50% reduction of TF in all cells or a selective reduction of TF in hematopoietic cells does not affect the development of atherosclerotic lesions in 2 mouse models. TF does not contribute to the progression of atherosclerosis in mice.


Key Words: atherosclerosis • macrophages • mice • tissue factor




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman and M. B. Taubman
Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease?
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 601 - 603.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. M. Wilson, R. B. McCaw, L. Leo, E. Arning, S. Lhotak, T. Bottiglieri, R. C. Austin, and S. R. Lentz
Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 233 - 240.
[Abstract] [Full Text] [PDF]